Gastric cancer incidence and mortality decreased substantially over the last decades in most countries worldwide, with differences in the trends and distribution of the main topographies across regions. To monitor recent mortality trends and to compute short-term predictions (2015) of gastric cancer mortality in selected countries worldwide, we analysed mortality data provided by the World Health Organization. We also analysed incidence of cardia and non-cardia cancers using data from Cancer Incidence in Five Continents (2003Continents ( -2007. The joinpoint regression over the most recent calendar periods gave estimated annual percent changes (EAPC) around À3% for the European Union (EU) and major European countries, as well as in Japan and Korea, and around À2% in North America and major Latin American countries. In the United States of America (USA), EU and other major countries worldwide, the EAPC, however, were lower than in previous years. The predictions for 2015 show that a levelling off of rates is expected in the USA and a few other countries. The relative contribution of cardia and non-cardia gastric cancers to the overall number of cases varies widely, with a generally higher proportion of cardia cancers in countries with lower gastric cancer incidence and mortality rates (e.g. the USA, Canada and Denmark). Despite the favourable mortality trends worldwide, in some countries the http://dx.
Introduction
Gastric cancer is the fourth most common cancer and the second leading cause of cancer deaths worldwide, despite its incidence and mortality have been appreciably declining for several decades [1] [2] [3] . The fall in gastric cancer is mainly due to the decline in the prevalence of Helicobacter pylori (H. pylori) infection and tobacco smoking, and to the improvements in food preservation and diet [4] . However, the patterns in gastric cancer trends vary substantially across geographical regions [3, 5] , reflecting a heterogeneous distribution of the factors associated with gastric cancer incidence, survival and mortality, with time, over birth cohorts and across countries (Fig. 1) .
The burden of gastric cancer remains very high in several countries from Asia, Latin America and Central and Eastern Europe, whereas in North America and in most Western European countries it is no longer a common cancer [1, 3, 6] . Incidence rates showed differences according to tumour topography [7, 8] , with upward trends in cardia incidence [9, 10] . The validity of data on gastric cancer subtypes is, however, open to discussion [11] .
To monitor recent trends in gastric mortality worldwide, and to compute short-term predictions for selected countries, we analysed mortality data provided by the World Health Organization (WHO) [12] . We also analysed the incidence of cardia and non-cardia cancers in selected countries worldwide, using available data from Cancer Incidence in Five Continents (CI5) [6] .
Methods

Gastric cancer mortality
We derived official data for gastric cancer mortality in 41 European countries and in 21 countries from other areas of the world from the WHO online database, for the period 1980-2011 [12] .
In Europe (defined as the WHO European region), we considered a few countries of the former Soviet Union (i.e. Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan and Uzbekistan), even though some of them had low national coverage and completeness. For the American continent, 13 countries with satisfactory death certification coverage and completeness were included (i.e. Canada, United States of America (USA), Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Ecuador, Mexico, Puerto Rico, Uruguay and Venezuela). Mortality data from gastric cancer were also available for four Asian countries (i.e. Hong Kong, Japan, the Fig. 1 . Chronology of landmarks with potential impact on gastric cancer incidence, survival and/or mortality. * -Stages of cigarette epidemic for developed countries [60] , ** - [61] , -Dissemination of food refrigeration in the United States [62] , à -Dissemination of food refrigeration in Japan [62] , k -Prevalence of obesity [63] [64] [65] , V -Prevalence of Helicobacter pylori infection [27, 32, 33] , / - [66] , W - [66] , ( - [67] , N - [68] , R - [69] , k - [70] , P - [71] , u - [47] , # - [47] , D - [72] , q - [45] , - [46] .
Republic of Korea and Singapore), for one African country (Mauritius), and for Australia and New Zealand.
Since three different Revisions of the International Classification of Diseases (ICD) were used in the period considered, we extracted, as applicable, those corresponding to the codes A047 (ICD-8) [13] , B091 (ICD-9) [14] and C16 (ICD-10) [15] . Population figures based on official censuses were also obtained from the WHO database [12] .
We computed country-and sex-specific mortality rates for each 5-year age group and calendar period, and derived age-standardised rates by the direct method, using the world standard population, for all ages and truncated at 35-64 years. For the European Union (EU) as a whole, rates were computed using the aggregated number of deaths in its 27 member states as defined in January 2007, and the corresponding populations; Cyprus was excluded as mortality data were only available for a limited number of recent years. Interpolation of missing data was made only for the construction of the EU rates; when data were not available for a country, the nearest available figures were replicated (i.e. generally those of the previous or subsequent year).
In order to identify significant changes in mortality trends for selected countries, we performed joinpoint regression analysis allowing for up to three joinpoints [16] . For each of the identified trends, we computed the estimated annual percent change (EAPC) by fitting a regression line to the natural logarithm of the rates using calendar year as a regression variable. The average annual percent change (AAPC), based on an underlying joinpoint model, was also calculated, and it was estimated as the geometric weighted average of the EAPCs, with the weights equal to the lengths of each time interval segment [17] .
For the EU as whole and for selected countries from different world regions, we computed predicted numbers of gastric cancer deaths and rates for the year 2015. These were derived by fitting a joinpoint model to each 5-year age-specific number of certified deaths, assuming a Poisson distribution, in order to identify the most recent trend segment [18] . Then, a linear regression was performed on mortality data from each age group over the time period identified by the joinpoint model as the most recent trend, in order to compute the predicted age-specific number of deaths, the corresponding 95% confidence intervals (CIs) and prediction intervals (PIs). The PI is a measure of uncertainty that accounts for the random nature of future predicted values, by adding an extra term in the standard error calculation [19] . We computed age-standardised mortality rates (and the corresponding 95% CIs and PIs) for 2015 using the predicted population data, obtained from Eurostat [20] , whenever available, and from The United Nations' Department of Economic and Social Affairs [21] , otherwise.
Gastric cancer incidence
We obtained incidence data from the most recent volume of CI5 -volume X [6] , corresponding to the period 2003-2007, and we considered gastric cancer incidence by topography defined as cardia (C16.0), non-cardia (fundus, C16.1; body, C16.2; pyloric, C16.3; pylorus, C16.4; lesser and greater curvature, C16.5-6) and other parts (C16.8-9) [15] . When data from more than one cancer registry were available in the same country, we added the number of incident cases from all registries.
We mapped the proportion of cardia and non-cardia cancers among those with known topography, by sex, using ArcGIS [22] . The analysis was restricted to countries with at least 20% of the cases with topography defined as cardia or non-cardia, and a minimum of 100 cases in these topography groups.
Results
Trends in mortality
The findings from the joinpoint regression over the period 1980-2011 in the 19 largest countries and in the EU as a whole are given in Figs. 2 and 3 and in Supplementary Table 1 .
Trends were significantly downward in all countries, for both men and women. In the EU as a whole, EAPCs over the most recent period were À3.7% in men and À3.4% in women, in the absence of substantial differences across the major European countries. Likewise, over the last two decades, the EAPC was around À3.0% in Russia and Ukraine in both sexes. The recent negative EAPCs in gastric mortality were even larger in Japan and Korea, for both sexes, while they were around À2.0% in the USA and most Latin American countries, despite the substantial variation of rates across those countries. However, in the USA, EU and several other major countries worldwide, the EAPCs were smaller than in previous calendar periods. Tables 1 and 2 give the age-standardised mortality rates from gastric cancer per 100,000 men and women, respectively, in various countries worldwide in 2000-2004 and 2005-2009 , and the corresponding percent changes. Gastric cancer mortality fell in most countries, with similar relative declines for both all ages and the truncated (35-64 years) age groups. The relative declines were above 20% in a few Northern and Central European countries, Costa Rica, Singapore and the Republic of Korea (for both sexes), in Puerto Rico, Australia and New Zealand (for men), and in Mauritius and Hong Kong (for women). Only in Denmark and in few For the EU as a whole, the rate was 8.0/100,000 men. In women, the highest rates (/100,000) were observed in Ecuador (10.5), the Russian Federation (10.1) and the Republic of Korea (9.2), whereas the lowest ones were in the USA (1.3), Canada (1.7) and France (1.9). In EU women, the overall gastric cancer mortality rate was 3.7/100,000.
Short-term predictions of mortality rates
Persisting favourable trends in overall male and female gastric cancer mortality rates are predicted up to 2015 ( Figs. 2 and 3 , respectively, and Supplementary  Table 2A and B). However, a levelling off in the falls is expected in the USA, and a few other countries, particularly at middle-age. In men, the 2015 predicted agestandardised gastric mortality rate/100,000 (number of deaths) is 6.2 (%33,900) in the EU, 4.4 (%2900) in France, 5.2 (%5400) in Germany, 5.8 (%5000) in Italy, 21.1 (%18,100) in Russia and 6.9 (%3600) in Spain. Outside Europe, predicted rates/100,000 (number of deaths) in men are 6.8 (%1800) in Argentina, 8.8 (%9500) in Brazil, 5.7 (%3300) in Mexico, 2.3 (%6400) in the USA, 16.1 (%32,500) in Japan and 17.6 (%6800) in Korea ( Supplementary Table 2A ). Corresponding values for women are 2.7 (%20,200) in the EU, 1.6 (%1400) in France, 2.5 (%3500) in Germany, 3.2 (%3700) in Italy, 8.4 (%13,800) in Russia and 3.1 (%2100) in Spain. Predicted rates for women are 2.8 (%1000) in Argentina, 3.7 (%5100) in Brazil, 3.7 (%2700) in Mexico, 1.2 (%4100) in the USA, 5.4 (%16,200) in Japan and 6.4 (%3500) in Korea ( Supplementary Table 2B ).
Distribution of gastric cardia and non-cardia cases
Figs. 4 and 5 give the proportion of cardia and noncardia gastric cancers in men and women, respectively, for selected countries from Europe (A) and other world regions (B). For men, among European countries, the proportion of cardia ranged between 11.6% (Belarus) and 72.0% (Finland), being higher in Northern and Central Europe and lower in Southern and Eastern Europe ( Fig. 4A and Supplementary Table 3 ). Among other countries worldwide ( Fig. 4B and Supplementary  Table 3 ), the highest proportion of cardia cancers was observed in countries with low mortality rates, while those with high rates had the lowest proportion of cardia cancers. The proportion of cardia ranged between 5.8% (Republic of Korea) and 64.8% (Iran). For women, we observed a similar geographic pattern, even though the total number of cases and the proportion of cardia cancers were lower. The proportion ranged between 10.6% (Italy) and 44.5% (United Kingdom), among large European countries ( Fig. 5A and Supplementary Table 4 ), and from 4.3% (Republic of Korea) to 31.5% (Australia), among other countries worldwide ( Fig. 5B and Supplementary Table 4 ).
Discussion
This updated analysis of worldwide gastric cancer mortality patterns and trends confirms that mortality rates continued to decrease in most countries worldwide over the last few years, although there still is a substantial variation (up to 10-fold) in rates across countries, and in some of them the declines are smaller -not only in absolute, but also in proportional terms -than in the past.
These analyses are based on data from the WHO database [12] and rely on the completeness and quality of the data provided by each country. Death certification from gastric cancer is sufficiently reliable and valid to permit inference on trends in most countries considered, especially at age 35-64 years. However, there are some differences in the coverage of death certification, particularly in some countries from the former Soviet Union and from Latin America, and no data are available from most African and Asian countries, thus precluding a more comprehensive picture of gastric mortality trends.
The mortality trends reflect the differences in exposure to the main risk factors for gastric cancer [4, [23] [24] [25] across populations, age-groups, and cohorts of birth over different time periods [26] .
Helicobacter pylori infection is the key determinant of gastric cancer and possibly a necessary cause [4] . In the late 1980s/early 1990s the prevalence of H. Pylori was below 20% among young adults in the USA [27] and in several high-income countries particularly from Western and Northern Europe [28, 29] , whereas in Portugal [5] , Latvia [30] or Chile [31] the prevalence was two to fourfold higher in the late 1990s/early 2000s. In the Republic of Korea [32, 33] and Japan [34] -currently presenting some of the highest gastric cancer mortality -the prevalence of H. pylori was high in the early 1990s, although most recent data show lower prevalence estimates. Since H. pylori infection is acquired mainly during childhood, this most likely reflects the replacement of the older generations that had been infected in their early lives, by younger subjects with a lower risk of infection [33, 35] . The distinct patterns in the prevalence of H. pylori infection may explain the fact that -despite the similar economic development in the USA, the EU and Japan -there are major differences in the burden of gastric cancer across these countries; if the observed trends remain the same in the future, it would take at least three decades for Japan and two decades for the EU to reach recent US rates. The decline in gastric cancer has become gradually smaller in some countries, particularly the USA. In France, mortality rates are predicted not to further decrease over the next years in the middle-aged population, in agreement with a less favourable tendency in most recent cohorts [26] . This is probably explained by the fact that a low and stable prevalence of H. pylori infection has been achieved in these countries long time ago.
Tobacco consumption -which also accounts for a sizable proportion of gastric cancer cases [36] -has been long declining in men from most of the countries with the lowest gastric cancer mortality [37] , while trends in smoking have been less favourable in Southern or Eastern Europe [37, 38] . In Japan, smoking prevalence has been high among men, particularly among those born before the late 1950s [39] . 
Proportion of Cardia and Non-cardia cases in
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According to Soerjomataram et al. [40] , if southern and eastern European countries with higher stomach cancer rates (Portugal, Estonia and Lithuania) presented the same patterns for H. pylori and smoking prevalence as northern countries (Denmark, Sweden), more than 50% of the stomach cancer cases observed in 2002 (%48,000) would be avoidable [40] .
The eradication of H. pylori infection is an important preventive and therapeutic measure for mucosa-associated lymphoid tissue (MALT) lymphoma, which accounts for about 50% of gastric lymphomas [41] , and for which incidence has been decreasing [42] . However, this measure is only recommended for primary prevention of gastric cancer in high risk areas and high risk individuals [43] .
The gradual improvements in gastric cancer diagnosis -new endoscopy and staging techniques, such as computerised tomography scanning, endoscopic ultrasound -and treatment -introduction of chemoradiotherapy after surgery [44] , perioperative chemotherapy [45] , new molecularly targeted therapy for both treatment and palliative care [46] and centralisation of surgical care [47] -may have had some role in the observed trends. However, gastric cancer survival has remained unsatisfactorily low in most areas of the world [48] . This may reflect, at least partially, the outweighing of the impact of these advances in disease management by the increasing contribution of gastric cancer cases located in the cardia [49, 50] and with diffuse histological type [51, 52] , which present worse prognosis [53] . Screening programs have been implemented in Korea [54] and Japan [55] , but these cannot explain the decrease observed in other world regions.
In relation to gastric cancer incidence, there is a wide variation in the relative contribution of cardia and noncardia cancers to the overall number of cases, with a generally higher proportion of the former among countries with higher gastric cancer rates. This is in accordance with the levelling off of mortality rates in several high-income countries, and suggests that cardia cancer would be responsible for an increasingly higher gastric cancer burden in the future. However, our results by gastric cancer subtypes must be interpreted with caution since, in some countries, incidence data had only a regional coverage, and because, in most cancer registries, a large proportion of gastric cancer cases had unknown or unspecified topography. Although in our analysis this limitation was partially overcome by selecting only the countries with a larger number of classified cases, it shows the importance of improving the monitoring of gastric cancer incidence.
In conclusion, despite the global downward trends in gastric cancer mortality, further declines in gastric cancer mortality rates may require more intensive efforts for the prevention and control of H. pylori infection [43] and other risk factors, including tobacco and diet [56] , as well as exposures associated with cancer of the cardia, such as reflux disease [57] and obesity [58] , which have been increasing in Central and Northern Europe [59] and in North America [8] . Moreover, there is still the need for intervention to improve early diagnosis and management in high risk countries, some of which are now high-income settings. Prevention of cardia cancers has become a priority in several regions.
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